MedTrace Logo

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

NCT04639804 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-11-23

No results posted yet for this study

Summary

This study aims to evaluate the pharmacokinetic (PK) interaction between tegoprazan and non-steroidal anti-inflammatory drugs (NSAIDs) after given each alone and in their combination in healthy male adults.

Conditions

  • Healthy

Interventions

DRUG

Tegoprazan

Tegoprazan 50 mg tablet

DRUG

Naproxen

Naproxen 500 mg tablet

DRUG

Aceclofenac

Aceclofenac 100 mg tablet

DRUG

Celecoxib

Celecoxib 200 mg capsule

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Min-Gul Kim, MD, PhD · Chonbuk university hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-06
Primary Completion
2020-07-26
Completion
2020-07-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04639804 on ClinicalTrials.gov